"Zai" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonZai Lab Limited (NASDAQ:ZLAB) Analysts Are Cutting Their Estimates: Here's What You Need To Know ...
Zai Lab Limited (NASDAQ:ZLAB) Analysts Are Cutting Their Estimates: Here's What You Need To Know simplywall.st
Zai Lab Ltd (ZLAB) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges...
Zai Lab Ltd (ZLAB) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges Yahoo Finance
Zai Lab Announces Third Quarter 2025 Financial Results and Recent Corporate Updates - Business Wire
Zai Lab Announces Third Quarter 2025 Financial Results and Recent Corporate Updates Business Wire
Triple meeting 2025 – Zai discloses pivotal DLL3 plans | ApexOnco - Clinical Trials news and anal...
Triple meeting 2025 – Zai discloses pivotal DLL3 plans | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Zai Lab Q3 2025 Earnings Preview - MSN
Zai Lab stock hits 52-week low at 23.16 USD - Investing.com
Zai Lab stock hits 52-week low at 23.16 USD Investing.com
Zai Lab Reports Strong Q3 2025 Results and Pipeline Progress - TipRanks
Zai Lab Reports Strong Q3 2025 Results and Pipeline Progress TipRanks
Zai Lab Ltd reports results for the quarter ended September 30 - Earnings Summary - TradingView
Zai Lab Ltd reports results for the quarter ended September 30 - Earnings Summary TradingView
Bank of America Securities Keeps Their Hold Rating on Zai Lab (ZLAB) - The Globe and Mail
Bank of America Securities Keeps Their Hold Rating on Zai Lab (ZLAB) The Globe and Mail
Zai Lab is Now Oversold (ZLAB) - Nasdaq
What Does The Future Hold For Zai Lab Limited (NASDAQ:ZLAB)? These Analysts Have Been Cutting The...
What Does The Future Hold For Zai Lab Limited (NASDAQ:ZLAB)? These Analysts Have Been Cutting Their Estimates Yahoo Finance
Analyst Forecasts Just Became More Bearish On Zai Lab Limited (NASDAQ:ZLAB) - simplywall.st
Analyst Forecasts Just Became More Bearish On Zai Lab Limited (NASDAQ:ZLAB) simplywall.st
Earnings call transcript: Zai Lab Q3 2025 reports revenue miss, stock dips - Investing.com
Earnings call transcript: Zai Lab Q3 2025 reports revenue miss, stock dips Investing.com
Zai Lab Ltd’s Earnings Call: Mixed Outlook Amid Growth and Challenges - TipRanks
Zai Lab Ltd’s Earnings Call: Mixed Outlook Amid Growth and Challenges TipRanks
Zai Lab Reports Strong Q3 2025 Growth and Pipeline Progress - The Globe and Mail
Zai Lab Reports Strong Q3 2025 Growth and Pipeline Progress The Globe and Mail
World Lung 2025 – Ideaya challenges Zai Lab | ApexOnco - Clinical Trials news and analysis - Onco...
World Lung 2025 – Ideaya challenges Zai Lab | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Revenues Working Against Zai Lab Limited's (NASDAQ:ZLAB) Share Price Following 26% Dive - simplyw...
Revenues Working Against Zai Lab Limited's (NASDAQ:ZLAB) Share Price Following 26% Dive simplywall.st
Zai Lab earnings missed by $0.08, revenue fell short of estimates - Investing.com
Zai Lab earnings missed by $0.08, revenue fell short of estimates Investing.com
Zai Lab Limited Files Quarterly Report with SEC - TipRanks
ASCO 2025 – Amgen gets one over on Zai Lab | ApexOnco - Clinical Trials news and analysis - Oncol...
ASCO 2025 – Amgen gets one over on Zai Lab | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Decoding Zai Lab Ltd (ZLAB): A Strategic SWOT Insight - GuruFocus
Decoding Zai Lab Ltd (ZLAB): A Strategic SWOT Insight GuruFocus
Zai Lab Ltd (ZLAB) Q3 2025 Earnings: EPS Loss of $0.03 Beats Est - GuruFocus
Zai Lab Ltd (ZLAB) Q3 2025 Earnings: EPS Loss of $0.03 Beats Est GuruFocus
Amgen and Zai Lab eye a gastric niche | ApexOnco - Clinical Trials news and analysis - Oncology P...
Amgen and Zai Lab eye a gastric niche | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Zai Lab Ltd expected to post a loss of 26 cents a share - Earnings Preview - TradingView
Zai Lab Ltd expected to post a loss of 26 cents a share - Earnings Preview TradingView
Zai Lab (NasdaqGM:ZLAB): Exploring Valuation After a 23% One-Month Share Price Decline - Yahoo Fi...
Zai Lab (NasdaqGM:ZLAB): Exploring Valuation After a 23% One-Month Share Price Decline Yahoo Finance
Amgen halts gastric cancer trial after antibody 'did not meet our standard' of efficacy, exec say...
Amgen halts gastric cancer trial after antibody 'did not meet our standard' of efficacy, exec says Fierce Biotech
Zai Lab shares Phase 1 data for lung cancer drug that could spar with Amgen’s Imdelltra - Endpoin...
Zai Lab shares Phase 1 data for lung cancer drug that could spar with Amgen’s Imdelltra Endpoints News
Amgen-Zai stomach cancer candidate takes a turn with 'attenuated' OS benefits at final phase 3 an...
Amgen-Zai stomach cancer candidate takes a turn with 'attenuated' OS benefits at final phase 3 analysis Fierce Biotech
Could Zai Lab’s (ZLAB) Pipeline Milestone Reveal Shifting Dynamics in Its Oncology Growth Narrati...
Could Zai Lab’s (ZLAB) Pipeline Milestone Reveal Shifting Dynamics in Its Oncology Growth Narrative? Yahoo Finance
L.L. Bean Summer Intern Zai Yang ’27 Stars in Company Ad - Bowdoin College
L.L. Bean Summer Intern Zai Yang ’27 Stars in Company Ad Bowdoin College
Zai Lab Limited (ZLAB): A Bull Case Theory - Yahoo Finance
Zai Lab Limited (ZLAB): A Bull Case Theory Yahoo Finance
Zai Lab Announces Participation in Investor Conferences in November and December 2025 - Business ...
Zai Lab Announces Participation in Investor Conferences in November and December 2025 Business Wire
Trump ya ce bai kamata Afirka ta Kudu ta kasance cikin G20 ba, ba zai je taronta a Johannesburg b...
Trump ya ce bai kamata Afirka ta Kudu ta kasance cikin G20 ba, ba zai je taronta a Johannesburg ba TRT World
A Look at Zai Lab (NasdaqGM:ZLAB) Valuation Following Key Clinical Progress and New Data Announce...
A Look at Zai Lab (NasdaqGM:ZLAB) Valuation Following Key Clinical Progress and New Data Announcement Yahoo Finance
Zai Yang ’27 launches Polar Plate website - The Bowdoin Orient
Zai Yang ’27 launches Polar Plate website The Bowdoin Orient
Zai Lab Announces Oral Presentation of Updated Data from Global Phase 1 Trial of Zocilurtatug Pel...
#ESMO25: Amgen, Zai Lab detail reduced survival benefit in stomach cancer trial - Endpoints News
#ESMO25: Amgen, Zai Lab detail reduced survival benefit in stomach cancer trial Endpoints News
Zai Lab looks towards an accelerated pathway | ApexOnco - Clinical Trials news and analysis - Onc...
Zai Lab looks towards an accelerated pathway | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Zai Lab to Announce Third Quarter 2025 Financial Results and Recent Corporate Updates on November...
Zai Lab to Announce Third Quarter 2025 Financial Results and Recent Corporate Updates on November 6, 2025 Business Wire
Zai Lab's Q3 Loss Narrows as Revenue Jumps 14%; Shares Fall 8% - MarketScreener
Zai Lab's Q3 Loss Narrows as Revenue Jumps 14%; Shares Fall 8% MarketScreener
Earnings Flash (ZLAB) Zai Lab Limited Reports Q3 Revenue $116.1M, vs. FactSet Est of $141.7M - Ma...
Earnings Flash (ZLAB) Zai Lab Limited Reports Q3 Revenue $116.1M, vs. FactSet Est of $141.7M MarketScreener
Kamaru: Sau nawa Paul Biya zai yi mulki? - DW
Rumored Trump Move Rattles China-Based Biotech Stocks - Investor's Business Daily
Rumored Trump Move Rattles China-Based Biotech Stocks Investor's Business Daily
Zai Lab Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Zai Lab Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag Yahoo Finance
Here's What Analysts Are Forecasting For Zai Lab Limited (NASDAQ:ZLAB) After Its Second-Quarter R...
Here's What Analysts Are Forecasting For Zai Lab Limited (NASDAQ:ZLAB) After Its Second-Quarter Results Yahoo Finance
Earnings Flash (ZLAB) Zai Lab Limited Reports Q3 Loss of $0.33 per ADS - MarketScreener
Earnings Flash (ZLAB) Zai Lab Limited Reports Q3 Loss of $0.33 per ADS MarketScreener
Zai Lab Limited's (NASDAQ:ZLAB) Profit Outlook - Yahoo Finance
Zai Lab Limited's (NASDAQ:ZLAB) Profit Outlook Yahoo Finance
Zai Lab Announces Updated Phase 1 Data for Zocilurtatug Pelitecan (formerly ZL-1310), Demonstrati...
Zai Lab (ZLAB) to Release Quarterly Earnings on Thursday - MarketBeat
Zai Lab (ZLAB) to Release Quarterly Earnings on Thursday MarketBeat
Zai Lab Announces Approval of TIVDAK® for Patients with Recurrent or Metastatic Cervical Cancer i...
Zai Lab Announces Approval of TIVDAK® for Patients with Recurrent or Metastatic Cervical Cancer in Hong Kong Yahoo Finance
Will Zai Lab Limited (Common Stock) (1ZL) stock benefit from commodity supercycle - July 2025 Pri...
Zai Lab Announces Second Quarter 2025 Financial Results and Recent Corporate Updates - Business Wire
Zai Lab Announces Second Quarter 2025 Financial Results and Recent Corporate Updates Business Wire
Fu Zai, China's first police corgi, racks up followers on social media - NPR
Fu Zai, China's first police corgi, racks up followers on social media NPR
Institutional investors may overlook Zai Lab Limited's (NASDAQ:ZLAB) recent US$260m market cap dr...
Zai Lab Ltd (ZLAB) Delivers Positive Results for Potential Gastric Cancer Treatment - Yahoo Finance
Zai Lab Ltd (ZLAB) Delivers Positive Results for Potential Gastric Cancer Treatment Yahoo Finance
Amgen's FGFR2b-targeting cancer candidate boosts overall survival in phase 3 - Fierce Biotech
Amgen's FGFR2b-targeting cancer candidate boosts overall survival in phase 3 Fierce Biotech
Stocks Showing Improved Relative Strength: Zai Lab ADR - Investor's Business Daily
Stocks Showing Improved Relative Strength: Zai Lab ADR Investor's Business Daily
Zai Lab Announces Participation in Investor Conferences in September 2025 - Business Wire
Zai Lab Announces Participation in Investor Conferences in September 2025 Business Wire
Why Zai Lab Limited Depositary Receipt stock is rated strong buy - 2025 Earnings Impact & Weekly ...
Why Zai Lab Limited Depositary Receipt stock is rated strong buy - 2025 Earnings Impact & Weekly Chart Analysis and Guides fcp.pa.gov.br
BBC Content Job: Zai Bennett Drops Out Of Charlotte Moore Race - Deadline
BBC Content Job: Zai Bennett Drops Out Of Charlotte Moore Race Deadline
Zai Lab Announces China National Medical Products Administration Grants Innovative Medical Device...
Zai Lab Announces China National Medical Products Administration Grants Innovative Medical Device...
Zohran Mamdani ya zama Magajin birnin New York - DW
Ko firaministan Nijar zai taimaki kasar? - DW
Cantor Fitzgerald Remains a Buy on Zai Lab (ZLAB) - The Globe and Mail
Cantor Fitzgerald Remains a Buy on Zai Lab (ZLAB) The Globe and Mail
Zai Lab Limited Is Well Positioned For Long-Term Growth - Seeking Alpha
Zai Lab Limited Is Well Positioned For Long-Term Growth Seeking Alpha
Zai Lab Limited (ZLAB): Among the Best Breakout Stocks to Buy According to Analysts - Yahoo Finance
Zai Lab Limited (ZLAB): Among the Best Breakout Stocks to Buy According to Analysts Yahoo Finance
Zai Lab Receives U.S. FDA Fast Track Designation for ZL-1310, a DLL3-Targeted Antibody-Drug Conju...
Why Zai Lab Limited (1ZLB) stock appeals to dividend investors - 2025 Bull vs Bear & Real-Time Bu...
Why Zai Lab Limited (1ZLB) stock appeals to dividend investors - 2025 Bull vs Bear & Real-Time Buy Zone Alerts fcp.pa.gov.br
Zai Lab Limited (ZLAB): Among Stocks Insiders Sold in April After Trump’s Tariff Rollout - Yahoo ...
Zai Lab Limited (ZLAB): Among Stocks Insiders Sold in April After Trump’s Tariff Rollout Yahoo Finance
Zai Lab Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor ...
Here's What Key Metrics Tell Us About Zai Lab Limited (ZLAB) Q2 Earnings - Nasdaq
Here's What Key Metrics Tell Us About Zai Lab Limited (ZLAB) Q2 Earnings Nasdaq
Zai Lab Ltd (ZLAB) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Ya...
Zai Lab Ltd (ZLAB) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... Yahoo Finance
Zai Lab to Announce Second Quarter 2025 Financial Results and Recent Corporate Updates on August ...
Zai Lab to Announce Second Quarter 2025 Financial Results and Recent Corporate Updates on August 7, 2025 Business Wire
Zai Lab Presents Positive Phase 1 Data for ZL-1310, a DLL3-Targeted ADC, Demonstrating Robust Ant...
Amgen and Zai Lab’s trial of gastric cancer therapy meets primary endpoint - Yahoo Finance
Amgen and Zai Lab’s trial of gastric cancer therapy meets primary endpoint Yahoo Finance
ZAI LAB Slumps 8% to 1-Yr+ Low; 3Q Results Miss - AASTOCKS.com
ZAI LAB Slumps 8% to 1-Yr+ Low; 3Q Results Miss AASTOCKS.com
Why Zai Lab Limited Depositary Receipt stock is rated strong buy - Quarterly Risk Review & Verifi...
Why Zai Lab Limited Depositary Receipt stock is rated strong buy - Quarterly Risk Review & Verified Swing Trading Watchlists fcp.pa.gov.br
Is Zai Lab Limited (ZLAB) the Best Performing Growth Stock in 2025? - Yahoo Finance
Is Zai Lab Limited (ZLAB) the Best Performing Growth Stock in 2025? Yahoo Finance
Zai Lab's TIVDAK Approved In Hong Kong For Advanced Cervical Cancer Treatment - Nasdaq
Zai Lab's TIVDAK Approved In Hong Kong For Advanced Cervical Cancer Treatment Nasdaq
Zai Lab to Announce First Quarter 2025 Financial Results and Recent Corporate Updates on May 8, 2...
Zai Lab to Announce First Quarter 2025 Financial Results and Recent Corporate Updates on May 8, 2025 Business Wire
Stocks Showing Rising Market Leadership: Zai Lab ADR Earns 82 RS Rating - Investor's Business Daily
Stocks Showing Rising Market Leadership: Zai Lab ADR Earns 82 RS Rating Investor's Business Daily
Zai Labs announces positive results in China arm of Phase III cervical cancer trial - Clinical Tr...
Zai Labs announces positive results in China arm of Phase III cervical cancer trial Clinical Trials Arena
Zai Lab Presents New Preclinical Data for ZL-1503, an IL-13/IL-31R Bispecific Antibody for the Tr...
Can Zai Lab Limited (1ZLB) stock stage a strong rebound this quarter - Weekly Market Outlook & We...
Amgen, Zai Lab say stomach cancer drug's survival benefit dropped in Phase 3 - Endpoints News
Amgen, Zai Lab say stomach cancer drug's survival benefit dropped in Phase 3 Endpoints News
How Zai Lab Limited Depositary Receipt stock compares to industry benchmarks - Long Setup & Daily...
How Zai Lab Limited Depositary Receipt stock compares to industry benchmarks - Long Setup & Daily Chart Pattern Signals fcp.pa.gov.br
With 73% ownership in Zai Lab Limited (NASDAQ:ZLAB), institutional investors have a lot riding on...
With 73% ownership in Zai Lab Limited (NASDAQ:ZLAB), institutional investors have a lot riding on the business Yahoo Finance
Zai Lab Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Update...
Zai Lab Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Updates Business Wire
Energy, atmosphere impressed DL Zai’Vion Meads during trip to Madison - 247Sports
Energy, atmosphere impressed DL Zai’Vion Meads during trip to Madison 247Sports
Zai Lab to Present New Data from Internally Developed, Next-Generation Oncology Candidates at AAC...
Zai Lab Announces First Quarter 2025 Financial Results and Recent Corporate Updates - BioSpace
Zai Lab Announces First Quarter 2025 Financial Results and Recent Corporate Updates BioSpace
Zai Lab (ZLAB) Delivers Positive ZL-1503 Trial Results in Treatment of Atopic Dermatitis - Yahoo ...
Zai Lab (ZLAB) Delivers Positive ZL-1503 Trial Results in Treatment of Atopic Dermatitis Yahoo Finance
Zai Lab Ltd (ZLAB) Q4 2024 Earnings Call Highlights: Robust Revenue Growth and Path to Profitabil...
Zai Lab Ltd (ZLAB) Q4 2024 Earnings Call Highlights: Robust Revenue Growth and Path to Profitability Yahoo Finance
Is Zai Lab Limited (1ZLB) stock ideal for retirement investors - 2025 Growth vs Value & Accurate ...
Is Zai Lab Limited (1ZLB) stock ideal for retirement investors - 2025 Growth vs Value & Accurate Technical Buy Alerts fcp.pa.gov.br
Meet Zai . | Fine art photographer & Cinematographer - SHOUTOUT LA
Meet Zai . | Fine art photographer & Cinematographer SHOUTOUT LA
Zai Lab, Vertex Pharmaceuticals announce povetacicept license agreement - Yahoo Finance
Zai Lab, Vertex Pharmaceuticals announce povetacicept license agreement Yahoo Finance
Zai Bennett unveils BBCS Productions leadership changes - Televisual
Zai Bennett unveils BBCS Productions leadership changes Televisual
Zai Lab Announces Acceptance of Biologics License Application for TIVDAK for the Treatment of Pat...
Meet Fu Zai, China's First Police Corgi With 400,000 Followers And A Nose For Trouble - NDTV
Meet Fu Zai, China's First Police Corgi With 400,000 Followers And A Nose For Trouble NDTV